Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-09-021724
Filing Date
2009-11-05
Accepted
2009-11-05 08:46:51
Documents
2
Period of Report
2009-11-03

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 3457
2 lazaruspoa.txt EX-24 12375
  Complete submission text file 0001225208-09-021724.txt   17816
Mailing Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 908 423 1688
Merck & Co. Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 142 WEST 57TH STREET NEW YORK NY 10019
Business Address
LAZARUS ROCHELLE B (Reporting) CIK: 0001082206 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0201
Type: 3 | Act: 34 | File No.: 001-06571 | Film No.: 091159603
SIC: 5621 Retail-Women's Clothing Stores